Hepatitis E-associated encephalopathy in a renal transplant recipient

BMJ Case Reports

Volumn , Issue , 2014, Pages

  De Vries, Marijke A ^a   Samijn, Johnny P A ^a   De Man, Rob ^b   Boots, Johannes M M ^a  

^a Maasstad Hospital   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISOLONE; RIBAVIRIN; VIRUS RNA;

AGED; ARTHRALGIA; ARTICLE; ATAXIC GAIT; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CERVICAL SPINAL CORD INJURY; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CONFUSION; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; GENOTYPE; GRAFT RECIPIENT; HEARING IMPAIRMENT; HEMOLYTIC ANEMIA; HEPATITIS E; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED BLADDER EMPTYING; KIDNEY TRANSPLANTATION; LHERMITTE SIGN; LIVER BIOPSY; MALAISE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSORY NEUROPATHY; SEROLOGY; VERTEBRAL CANAL STENOSIS; VIRUS LOAD; WALKING AID;

EID: 84899682754     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-204244     Document Type: Article

References (15)

1. Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet 2012;379:2477-88.
2. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012;367:1237-44.
3. Meng X-J. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011;161:23-30.
4. Mansuy J-M, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011;17:2309-12.
5. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011;17:30-7.
6. Dalton HR, Bendall R, Ijaz S, et al. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008;8:698-709.
7. Matsubayashi K, Kang J-H, Sakata H, et al. A case of transfusion- transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008;48:1368-75.
8. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006;16:79-83.
9. Pas SD, de Man RA, Mulders C, et al. Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012;18:869-72.
10. Slot E, Hogema B, Riezebos-Brilman A, et al. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013;18:pii: 20550.
11. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011;17:173-9.
12. Cheung MCM, Maguire J, Carey I, et al. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol 2012;11:618-22.
13. Wéclawiack H, Kamar N, Mehrenberger M, et al. Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts. Nephrol Dial Transplant 2008;23:1043-7.
14. Zhu F-C, Zhang J, Zhang X-F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
15. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007;356:895-903. (Pubitemid 46339908)